Holding(s) in Company
26 February 2008 - 2:54AM
UK Regulatory
RNS Number:6951O
EiRx Therapeutics PLC
25 February 2008
TR-1: Notifications of Major Interests in Shares
Eirx Therapeutics Plc
1. Identity of the issuer or the underlying issuer of
existing shares to which voting rights are attached:
2. Reason for notification (yes/no)YES
An acquisition or disposal of voting rights NO
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
NO
An event changing the breakdown of voting rights
NO
Other (please specify):______________
3. Full name of person(s) subject to notification Share plc
obligation:
4. Full name of shareholder(s) (if different from The Share Centre Ltd
3):
5. Date of transaction (and date on which the 21 February 2008
threshold is crossed or reached if different):
6. Date on which issuer notified: 25 February 2008
7. Threshold(s) that is/are crossed or reached: 8%
8. Notified details: N/A
A: Voting rights attached to shares
Class/type of Situation previous to the Resulting situation after the triggering transaction
shares triggering transaction
Number of Number of Number of Number of voting rights Percentage of voting
If possible use shares voting shares rights
ISIN code rights
Direct Direct Indirect Direct Indirect
GB00B0XQBS97 8,227,056 8,227,056 246,996,816 0 246,996,816 0.00 8.30
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting
instrument period/date that may be acquired rights
(if the instrument
exercised/converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
246,996,816 8.30
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
The Share Centre Ltd
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: N/A
14 Contact name: Iain Wallace
15. Contact telephone name: 01296 439 410
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVVVRWURUUAR
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Eirx Therap. (London Stock Exchange): 0 recent articles
More Eirx Therapeutic Plc News Articles